PLATELET-ACTIVATING FACTOR IN THROMBOTIC PLATELET-LEUKOCYTE INTERACTIONS
血栓性血小板-白细胞相互作用中的血小板激活因子
基本信息
- 批准号:8039942
- 负责人:
- 金额:$ 41.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAcetyltransferaseAcuteAdhesionsAgonistAnimal ModelAntibodiesAntiphospholipid AntibodiesAspirinBlood PlateletsCD14 AntigenCellsClinicClinicalCoronaryDiseaseEndotoxinsEnzymesEventGTP-Binding ProteinsGenetic VariationHumanImmune systemIndividualInflammation MediatorsInflammatoryIntegrinsIschemiaKnowledgeLeadLecithinLeftLeukocytesLigandsLinkLipidsLipopolysaccharidesLipoproteinsLysophosphatidylcholinesMediator of activation proteinMyocardialOrganPathway interactionsPhospholipidsPlatelet Activating FactorPredispositionProcessProductionProstaglandin ProductionProstaglandin-Endoperoxide SynthaseProteinsReactionReceptor ActivationReperfusion InjuryReperfusion TherapyResearch PersonnelRoleRouteSepsisSignal TransductionSourceStentsSurfaceSystemTLR4 geneTechniquesTestingThromboplastinThrombosisThromboxane A2Thromboxane ProductionThromboxanesThrombusTimeTissuesTranslatingVasoconstrictor Agentscyclooxygenase 2cytokinedesigneicosanoid metabolismendotoxin receptorhemodynamicsin vivoinhibitor/antagonistleukocyte activationlipid mediatorlung injurynovelplatelet activating factor receptorprogramsreceptorreceptor functionsuccesssynthetic enzyme
项目摘要
The phospholipid Platelet-activating factor (PAF) is perhaps the most powerful pro-inflammatory and prothromobtic
lipid mediator yet defined. All cellular components of the acute inflammatory system express the
single known receptor for PAF. PAF is synthesized by, and retained on the surface of, activated endothelial
ceils where it stimulates tethered leukocytes. PAF accumulation normally is tightly controlled, but PAF has a
role in thrombosis, sepsis and reperfusion damage.
There are deficits in our knowledge of how, when, and where PAF receptor ligands are formed, how PAF is
presented to cells of the innate immune system and how PAF stimulated cells interact with other cells. We
do not know whether PAF receptor ligands are formed during stent placement, whether PAF stimulated
leukocytes provide platelets with substrate for thromboxane production even when platelet cyclooxygenase
has been inhibited by aspirin, and we do not know whether PAF production by leukocytes stimulated with
endotoxin is mimicked by endogenous agonists that include anti-phospholipid antibodies.
We propose to identify the pathways leading to activation of the rate-limiting PAF synthetic activity,
determine whether individuals vary in their ability to make PAF, take advantage of new information and
techniques to purify the enzyme responsible for PAF synthesis for eventual rational inhibitor design, and
identify and modulate mechanisms that cause microparticle formation and PAF release, and to determine
whether these parameters correlate with thrombosis. We will define the pro-thrombotic lipids released during
stent placement, we will investigate alternate routes to generate thromboxane Aa, and determine whether this
correlates with susceptibility to slow reflow after stent placement, and we will test alternate, endogenous
ligands of TLR4 as leukocyte agonists. We have four aims:
Aim 1. Mechanistically define adhesion-dependent PAF synthesis in PMN.
Aim 2. Purify and molecularly characterize the leukocyte PAF acetyltransferase synthetic enzyme.
Aim 3. Identify factors that extend the effect of PAF through microparticle release.
Aim 4. Define novel routes to leukocyte activation and inflammatory mediator production
磷脂血小板活化因子(PAF)可能是最强大的促炎和促血栓形成因子。
脂质介质尚未确定。急性炎症系统的所有细胞成分都表达
PAF的单一已知受体。PAF由活化的内皮细胞合成并保留在其表面,
刺激束缚的白细胞。PAF的积累通常是严格控制的,但PAF具有
在血栓形成、脓毒症和再灌注损伤中的作用。
我们对PAF受体配体如何、何时、在何处形成,PAF是如何在体内形成的,
呈现给先天免疫系统的细胞以及PAF刺激的细胞如何与其他细胞相互作用。我们
我不知道是否PAF受体配体在支架置入过程中形成,是否PAF刺激
白细胞为血小板提供血栓素生成的底物,即使当血小板环氧化酶
已被阿司匹林抑制,我们不知道是否由白细胞刺激PAF的产生,
内毒素被包括抗磷脂抗体在内的内源性激动剂模拟。
我们建议确定导致激活限速PAF合成活性的途径,
确定个体是否有不同的能力,使PAF,利用新的信息,
纯化负责PAF合成的酶的技术,用于最终合理的抑制剂设计,以及
鉴定和调节引起微粒形成和PAF释放机制,并确定
这些参数是否与血栓形成相关。我们将定义血栓形成过程中释放的促血栓脂质,
支架置入后,我们将研究产生血栓素Aa的替代途径,并确定这是否
与支架置入后对缓慢复流的敏感性相关,我们将测试替代的内源性
TLR4配体作为白细胞激动剂。我们有四个目标:
目标1。机械定义PMN中粘附依赖性PAF合成。
目标2.白细胞PAF乙酰转移酶合成酶的纯化和分子特征。
目标3。确定通过微粒释放延长PAF作用的因素。
目标4。定义白细胞活化和炎症介质产生的新途径
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS MCINTYRE其他文献
THOMAS MCINTYRE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS MCINTYRE', 18)}}的其他基金
PLATELET-ACTIVATING FACTOR IN THROMBOTIC PLATELET-LEUKOCYTE INTERACTIONS
血栓性血小板-白细胞相互作用中的血小板激活因子
- 批准号:
7493848 - 财政年份:2007
- 资助金额:
$ 41.2万 - 项目类别:
PLATELET-ACTIVATING FACTOR IN THROMBOTIC PLATELET-LEUKOCYTE INTERACTIONS
血栓性血小板-白细胞相互作用中的血小板激活因子
- 批准号:
7226379 - 财政年份:2006
- 资助金额:
$ 41.2万 - 项目类别:
PLATELET-ACTIVATING FACTOR IN THROMBOTIC PLATELET-LEUKOCYTE INTERACTIONS
血栓性血小板-白细胞相互作用中的血小板激活因子
- 批准号:
7615046 - 财政年份:
- 资助金额:
$ 41.2万 - 项目类别:
PLATELET-ACTIVATING FACTOR IN THROMBOTIC PLATELET-LEUKOCYTE INTERACTIONS
血栓性血小板-白细胞相互作用中的血小板激活因子
- 批准号:
7799803 - 财政年份:
- 资助金额:
$ 41.2万 - 项目类别:
相似海外基金
Dissecting out differential molecular phenotypes across Lysine(K) AcetylTransferase mutations in mouse development
剖析小鼠发育过程中赖氨酸(K)乙酰转移酶突变的差异分子表型
- 批准号:
10727966 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
靶向赖氨酸乙酰转移酶 MOF/KAT8 在肺癌中的作用
- 批准号:
10601761 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Defining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorder
定义组蛋白乙酰转移酶 KAT2a 在伏隔核 D1 中型多棘神经元中作为可卡因使用障碍驱动因素的细胞类型特异性作用
- 批准号:
10679238 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Roles of lysine acetyltransferase 6 complexes in cerebral development and neurodevelopmental disorders
赖氨酸乙酰转移酶 6 复合物在大脑发育和神经发育障碍中的作用
- 批准号:
479754 - 财政年份:2023
- 资助金额:
$ 41.2万 - 项目类别:
Operating Grants
Examination of the Histone Acetyltransferase CBP in the Remodelling of Thermogenic Adipose Tissues
组蛋白乙酰转移酶 CBP 在生热脂肪组织重塑中的检测
- 批准号:
486467 - 财政年份:2022
- 资助金额:
$ 41.2万 - 项目类别:
Studentship Programs
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10344246 - 财政年份:2022
- 资助金额:
$ 41.2万 - 项目类别:
Nuclear activity of carnitine acetyltransferase
肉毒碱乙酰转移酶的核活性
- 批准号:
RGPIN-2018-06089 - 财政年份:2022
- 资助金额:
$ 41.2万 - 项目类别:
Discovery Grants Program - Individual
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10627744 - 财政年份:2022
- 资助金额:
$ 41.2万 - 项目类别:
Structural and functional studies of histone acetyltransferase complexes
组蛋白乙酰转移酶复合物的结构和功能研究
- 批准号:
RGPIN-2018-03951 - 财政年份:2022
- 资助金额:
$ 41.2万 - 项目类别:
Discovery Grants Program - Individual
Characterizing the role of the NuA3 histone acetyltransferase complex during transcription
表征 NuA3 组蛋白乙酰转移酶复合物在转录过程中的作用
- 批准号:
557615-2021 - 财政年份:2022
- 资助金额:
$ 41.2万 - 项目类别:
Postdoctoral Fellowships